New Cloud Platform Seeks to Accelerate Cancer Care Collaboration
Intel has launched Collaborative Cancer Cloud, a new service to enable providers and researchers to securely share genomic, imaging and clinical data among participating organizations across the globe.
By 2020, the goal is to have physicians be able to give a patient a diagnosis and generate a specific treatment plan within 24 hours. Over time, the platform will be modified to support other types of research and treatment.
Intel developed the Collaborative Cancer Cloud (CCC) with the Knight Cancer Institute at Oregon Health & Science University and has conducted initial technical connecting of servers with OHSU as well as two other unidentified facilities in Austin and Boston.
The intent of initial testing of the platform was to prove that analytics could be shared across three sites without sharing actual patient data and without any site giving up control of their data, says Eric Dishman, general manager of Intels Health & Life Sciences Group.
Open source tools built for the CCC will create a secure container around a research issue that a researcher or physician wants to examine. For instance, a physician treating a specific cancer patient may want to find treatment results of other patients with the same condition and genetic mutations as the patient, explains Brian Druker, M.D., director of the Knight Cancer Institute at OSHU. The physician can send a query in a secure container through CCC to several sites asking for information on their patients with the same characteristics as the physicians patient, and receive back in a secure container the treatment regimens and results from other patients, but no identifying information.
Our focus on the federation/distribution of private datasets is complementary to the exciting work thats happening to make public data sets more accessible to research, Intels Dishman writes in a blog. In CCC, each partner will maintain control of its patients data, while the sharable cancer treatment knowledgebase grows in availability and impact.
General availability of the Collaborative Cancer Cloud is expected in the first quarter of 2016. There is no cost to join other than an organizations costs for putting the infrastructure in place. While starting with a focus on cancer, the infrastructure will support any other type of research, Dishman says.